Clinical Trial Update: Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the combination of docetaxel and ketoconazole for metastatic breast cancer and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Ketoconazole (Ketoconazole)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED